Biotome Pty Ltd: Funding, Investors & Team (Sep 2026)
We are developing next generation antibody diagnostics Built on the discovery of markers that identify high stomach cancer risk, Biotome was founded to benefit patients around the world. Our next-generation antibody tests surpass current antibody screening with enhanced precision and more detailed disease information.
Biotome Pty Ltd has raised $320k across 2 funding rounds on record, the most recent an undisclosed round of $320k announced in Nov 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biotome Pty Ltd Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Biotome Pty Ltd Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Biotome Pty Ltd announced an undisclosed round in Jun 2023; the amount was not disclosed.
2.4 years later, an undisclosed round of $320k was announced in Nov 2025.
Biotome Pty Ltd Founders and Leadership Team
Contact details for the Biotome Pty Ltd team: 1 of 2 have an email address on file.
Start 14-day free trial →Biotome Pty Ltd Funding Compared to Other Biotechnology Startups
Biotome Pty Ltd's latest round of $320k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biotome Pty Ltd in Biotechnology and Perth
Companies Similar to Biotome Pty Ltd
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Biotome Pty Ltd Funding FAQs
What does Biotome Pty Ltd do?
We are developing next generation antibody diagnostics Built on the discovery of markers that identify high stomach cancer risk, Biotome was founded to benefit patients around the world. Our next-generation antibody tests surpass current antibody screening with enhanced precision and more detailed disease information.
How much funding has Biotome Pty Ltd raised?
Biotome Pty Ltd has raised $320k across 2 rounds on record. The most recent is an undisclosed round of $320k announced in Nov 2025.
When did Biotome Pty Ltd last raise funding?
Biotome Pty Ltd's most recent funding round on record is an undisclosed round of $320k, announced in Nov 2025.
Who founded Biotome Pty Ltd?
FundedIQ lists Alma Fulurija (Founder), Barry Marshall (Founder) at Biotome Pty Ltd.
Where is Biotome Pty Ltd headquartered?
Biotome Pty Ltd is based in Perth, Western Australia, Australia.
How many employees does Biotome Pty Ltd have?
Biotome Pty Ltd is in the 1-10 employee band.
How does Biotome Pty Ltd's funding compare to other Biotechnology startups?
Biotome Pty Ltd's latest round of $320k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Biotome Pty Ltd Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biotome Pty Ltd is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.